Literature DB >> 8127351

Hydroxyurea in congenital erythropoietic porphyria.

L Guarini, S Piomelli, M B Poh-Fitzpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8127351     DOI： 10.1056/NEJM199404143301519

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.

Authors:  David F Bishop; Xiaoye Schneider-Yin; Sonia Clavero; Han-Wook Yoo; Elisabeth I Minder; Robert J Desnick
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

2.  Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.

Authors:  David F Bishop; Annika Johansson; Robert Phelps; Amr A Shady; Maria C M Ramirez; Makiko Yasuda; Andres Caro; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2006-02-09       Impact factor: 11.025

Review 3.  Congenital erythropoietic porphyria: Recent advances.

Authors:  Angelika L Erwin; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2018-12-27       Impact factor: 4.797

4.  The Porphyrias.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.